ACR responds to CMS Medicare Part D and Medicare Advantage proposed rule

(American College of Rheumatology) In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) expressed its continuing concern with a recent CMS policy allowing Medicare Advantage (MA) plans to utilize step therapy for Part B drugs. In the comment letter, rheumatology leaders urged the agency to establish safeguards to protect beneficiaries from potential harm.

https://www.eurekalert.org/pub_releases/2019-01/acor-art012419.php

Source: EurekAlert! - Medicine and Health - January 24, 2019 Category: International Medicine & Public Health Source Type: news

More News: Centers for Medicare and Medicaid Services (CMS) | Medicaid | Medicare | Rheumatology